AFP and hepatocellular carcinoma: A “serum biomarker model” containing tryptophan, glutamine, and 2-hydroxybutyric acid based on capillary electrophoresis−time-of-flight mass spectrometry is established to diagnose HCC from non-HCC, which is confirmed to be an effective biomarker that compensatory for AFP (Zeng et al., 2014).